Evolent Health Stock News

The company's stock climbed nearly $5 higher per share on Thursday over its closing price on Wednesday.

Evolent Health <> has added more than a tenth on Thursday morning hours to record the biggest intraday gain since July 2020. Read about the reason.

Lantheus LNTH +34%. Evolent Health (EVH) +18%. Orphazyme (ORPH) -36%. Rhythm Pharmaceuticals RYTM -24%.

EVH earnings call for the period ending December 31, 2021.

Evolent Health, Inc. (EVH) CEO Seth Blackley on Q4 2021 Results - Earnings Call Transcript

Evolent Health press release (EVH): Q4 Non-GAAP EPS of $0.08 beats by $0.07.Revenue of $248.36M (-8.7% Y/Y) beats by $11.88M.

WASHINGTON, Feb. 23, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter and full year ended December 31, 2021. Highlights from…

Evolent Health (NYSE:EVH) is scheduled to announce Q4 earnings results on Wednesday, Feb. 23, after market close.The consensus EPS estimate is $0.01 (vs. -$0.01 in year-ago period)

Evolent Health, Inc with ticker code (EVH) have now 5 analysts in total covering the stock. The consensus rating is ''Strong_Buy''. The target price ranges between 44 and 35 and has a mean target at 38.4. Now with the previous closing price of 23.32 this would imply there is a potential upside of 64.7%. The 50 day moving average now sits at 25.17 and the 200 day MA is 24.61. The company has a market capitalisation of $2,187m. Find out more information at: https://www.evolenthealth.com [stock_market_widget type="chart" symbol="EVH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $3,601m based on the market concensus. Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

WASHINGTON, Dec. 14, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today

Harel Insurance Investments & Financial Services Ltd. lessened its stake in Evolent Health, Inc. (NYSE:EVH) by 33.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,058 shares of the technology companys stock after selling 2,523 shares during the quarter. Harel []

Royal Bank of Canada boosted its position in Evolent Health, Inc. (NYSE:EVH) by 12.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,905 shares of the technology companys stock after acquiring an additional 2,051 shares during the quarter. Royal Bank of Canadas holdings []

Prudential Financial Inc. decreased its holdings in shares of Evolent Health, Inc. (NYSE:EVH) by 6.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,052 shares of the technology companys stock after selling 766 shares during the period. Prudential Financial []